Heterozygous germline mutations in bone morphogenetic protein receptor type 2 (BMPR2), a member of the transforming growth factor beta (TGF-β) superfamily, are the most common genetic cause of PAH [8–10]. Here, BMPR2 is linked to pulmonary arterial hypertension.